Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 11;21(24):9456.
doi: 10.3390/ijms21249456.

Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction

Affiliations
Review

Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction

Emelie Lassén et al. Int J Mol Sci. .

Abstract

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD), with prevalence increasing at an alarming rate worldwide and today, there are no known cures. The pathogenesis of DKD is complex, influenced by genetics and the environment. However, the underlying molecular mechanisms that contribute to DKD risk in about one-third of diabetics are still poorly understood. The early stage of DKD is characterized by glomerular hyperfiltration, hypertrophy, podocyte injury and depletion. Recent evidence of glomerular endothelial cell injury at the early stage of DKD has been suggested to be critical in the pathological process and has highlighted the importance of glomerular intercellular crosstalk. A potential mechanism may include reactive oxygen species (ROS), which play a direct role in diabetes and its complications. In this review, we discuss different cellular sources of ROS in diabetes and a new emerging paradigm of endothelial cell dysfunction as a key event in the pathogenesis of DKD.

Keywords: ROS; diabetic kidney disease; glomerular endothelial cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The glomerular filtration barrier. (A) Schematic showing a glomerular capillary loop that forms the primary filtering unit of the kidney, illustrating normal (left) and diabetic kidney disease (DKD) (right) morphology features. The glomerular capillary loop is comprised of specialized structures: parietal epithelial cells (PECs), the mesangial cells, visceral epithelial cells (podocytes) with interdigitating foot processes (FP) attached to the glomerular basement membrane (GBM), fenestrated glomerular endothelial cells (GEC), and the glycocalyx. Between podocyte foot processes is the slit diaphragm (SD), forming a bridge and tethering foot processes together. In DKD, there are profound morphological changes to the glomerulus, including thickening of the GBM, mesangial matrix expansion and increases in extracellular matrix deposition occluding its capillaries. Additional changes are GEC dysfunction, degradation of the glycocalyx, fusion of foot processes, disrupted architecture of the slit diaphragm, podocytes depletion and consequential protein leak. (B) There is disrupted bidirectional signaling among the cells in the filtration barrier in DKD, including increased podocyte-derived vascular endothelial growth factor a (VEGFA) in early DKD and decrease of VEGF in progressive disease. There is a loss of angiopoietin-1 (Angpt1) and tyrosine-protein kinase receptor (Tie2) interaction in diabetes, and production of activated protein C (APC) in the glomerulus is reduced because of suppression of thrombomodulin expression. Decreased functional activity of APC affects the permeability of the glomerular capillary wall and enhances apoptosis of GECs and podocytes. Endothelin-1 (Edn1) and endothelin receptor A (Ednra) pathway activation in DKD lead to mitochondrial oxidative stress, endothelial nitric oxide (NO) depletion, and degradation of the endothelial glycocalyx.
Figure 2
Figure 2
Generation of excess reactive oxygen species (ROS) in the GECs. Pathological metabolic conditions associated with diabetes mellitus (including hyperglycemia, increased circulation of advanced glycation end products (AGEs), endothelin-1 (Edn1) and free fatty acids (FFAs), as well as activation of RAAS leading to release of angiotensin II (Ang II)) can exacerbate ROS production over the cell’s antioxidant capacity, and this imbalance contributes to endothelial dysfunction in DKD. ROS are generated by enzymatic and nonenzymatic redox reactions during cellular metabolism under normal and pathological conditions. The superoxide anion (O2), generated in mitochondria, plasma membrane, peroxisomes, and cytosol, becomes the precursor free radical for the generation of other ROS molecules. Next, cytosolic CuZN superoxide dismutase (SOD) and mitochondrial MnSOD convert O2 to H2O2, which yields highly reactive hydroxyl radicals (OH•) by interaction with reduced transition metal ions (such as Fe and Cu) in a Fenton reaction. In addition to ROS, cells also generate reactive nitrogen species (RNS). The major RNS include nitric oxide (•NO), peroxynitrite (ONOO), and nitrogen dioxide (•NO2). Nitric oxide (•NO) is produced by three isoforms of nitric oxide synthase (NOS). Finally, the excess ROS produced causes oxidative damage to mitochondrial and nuclear DNA, lipid and protein oxidation, protein nitration, and mitochondrial dysfunction.

References

    1. Chapter 1: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. Am. J. Kidney Dis. 2019;73:S291–S332. doi: 10.1053/j.ajkd.2018.12.012. - DOI
    1. Ogurtsova K., da Rocha Fernandes J.D., Huang Y., Linnenkamp U., Guariguata L., Cho N., Cavan D., Shaw J., Makaroff L.E. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024. - DOI - PubMed
    1. Williams R., Karuranga S., Malanda B., Saeedi P., Basit A., Besançon S., Bommer C., Esteghamati A., Ogurtsova K., Zhang P., et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2020;162:108072. doi: 10.1016/j.diabres.2020.108072. - DOI - PubMed
    1. American Diabetes Association 11 Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2019;43:S135–S151. doi: 10.2337/dc20-s011. - DOI - PubMed
    1. Anders H.-J., Huber T.B., Isermann B., Schiffer M. CKD in diabetes: Diabetic kidney disease versus nondiabetic kidney disease. Nat. Rev. Nephrol. 2018;14:361–377. doi: 10.1038/s41581-018-0001-y. - DOI - PubMed

MeSH terms

Substances